Literature DB >> 30666968

Evaluation of hypertriglyceridemia-induced acute pancreatitis: A single tertiary care unit experience from Turkey.

Orhan Sezgin1, Osman Özdoğan1, Serkan Yaraş1, Enver Üçbilek1, Engin Altıntaş1.   

Abstract

BACKGROUND/AIMS: This study aimed to determine the frequency of hypertriglyceridemia (HTG)-induced acute pancreatitis (AP) and assess different clinical and prognostic features in these patients.
MATERIALS AND METHODS: The patients who were hospitalized with AP due to HTG (HTG-AP) between January 2005 and December 2014 were retrospectively evaluated in the clinic. The patients with AP due to non-HTG (non-HTG-AP) were also investigated during the same period.
RESULTS: Of 635 patients with AP admitted to the clinic, 33 (5.2%) had HTG-related AP. Mean triglyceride levels were 2653 mg/dL (range: 439-13700 mg/dL). Mean Ranson score at the time of admission was 1.5, and the APACHE II score was 4.63. The mean duration of hospitalization was 4.4 days (range: 2-14 days). One of these patients died on the sixth day of hospitalization due to multiple-organ failure. Patients with a triglyceride level of >1000 mg/dL were younger, had a longer hospital stay, and had a higher recurrence rate. Compared with non-HTG-AP, HTG-AP was observed at a younger age (57.4±17.3 vs. 37.6±14.8, p<0.05, respectively) and more frequently in males (45.2% vs. 57.6%, p<0.05, respectively). The frequency of multiple AP in patients with HTG-AP was higher than non-HTG-AP (63.4% vs. 7.6%, respectively).
CONCLUSION: HTG-AP was observed at a younger age and was responsible for most cases of recurrent pancreatitis. The duration of hospitalization was long, and the risk of recurrence and mortality were high in patients with HTG-AP having a triglyceride level >1000 mg/dL.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30666968      PMCID: PMC6428520          DOI: 10.5152/tjg.2018.18292

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  26 in total

Review 1.  Issues in hypertriglyceridemic pancreatitis: an update.

Authors:  John Scherer; Vijay P Singh; C S Pitchumoni; Dhiraj Yadav
Journal:  J Clin Gastroenterol       Date:  2014-03       Impact factor: 3.062

2.  Incidence and clinical features of hyperlipidemic acute pancreatitis from Guangdong, China: a retrospective multicenter study.

Authors:  Yao-Xing Huang; Lin Jia; Shu-Man Jiang; Sheng-Bing Wang; Ming-Xian Li; Bi-Hui Yang
Journal:  Pancreas       Date:  2014-05       Impact factor: 3.327

3.  Etiology, clinical features and management of acute recurrent pancreatitis.

Authors:  Yi Yun Deng; Rui Wang; Hao Wu; Cheng Wei Tang; Xin Zu Chen
Journal:  J Dig Dis       Date:  2014-10       Impact factor: 2.325

4.  Heparin and insulin in the treatment of hypertriglyceridemia-induced severe acute pancreatitis.

Authors:  Hakan Alagözlü; Mehmet Cindoruk; Tarkan Karakan; Selahattin Unal
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

5.  Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults.

Authors:  Jennifer B Christian; Nancy Bourgeois; Rose Snipes; Kimberly A Lowe
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

Review 6.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

7.  Dyslipidaemic pancreatitis clinical assessment and analysis of disease severity and outcomes.

Authors:  F Anderson; S R Thomson; D L Clarke; I Buccimazza
Journal:  Pancreatology       Date:  2009-04-29       Impact factor: 3.996

8.  Lipid-modifying therapies and risk of pancreatitis: a meta-analysis.

Authors:  David Preiss; Matti J Tikkanen; Paul Welsh; Ian Ford; Laura C Lovato; Marshall B Elam; John C LaRosa; David A DeMicco; Helen M Colhoun; Ilan Goldenberg; Michael J Murphy; Thomas M MacDonald; Terje R Pedersen; Anthony C Keech; Paul M Ridker; John Kjekshus; Naveed Sattar; John J V McMurray
Journal:  JAMA       Date:  2012-08-22       Impact factor: 56.272

9.  Clinical assessment of hyperlipidemic pancreatitis.

Authors:  M R Fortson; S N Freedman; P D Webster
Journal:  Am J Gastroenterol       Date:  1995-12       Impact factor: 10.864

10.  Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.

Authors:  Supna Sandhu; Ahmad Al-Sarraf; Catalin Taraboanta; Jiri Frohlich; Gordon A Francis
Journal:  Lipids Health Dis       Date:  2011-09-11       Impact factor: 3.876

View more
  4 in total

1.  Pitfalls in hypertriglyceridemia induced acute pancreatitis.

Authors:  Murat Saruç; Hakan Ümit Ünal
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

Review 2.  Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research.

Authors:  Lu Wang; Ting Xu; Ruifeng Wang; Xiaobing Wang; Dong Wu
Journal:  Dig Dis Sci       Date:  2021-05-03       Impact factor: 3.199

3.  The role of comorbid hypertriglyceridemia and abdominal obesity in the severity of acute pancreatitis: a retrospective study.

Authors:  Xiaoxi Yang; Jiajun He; Shuli Ma; Tingting Wang; Quping Zhu; Fei Cao; Yuanhao Li; Chuting Yang; Chaowu Chen; Guotao Lu; Lianghao Hu; Jun Liu; Weiwei Chen
Journal:  Lipids Health Dis       Date:  2021-11-27       Impact factor: 3.876

Review 4.  Hypertriglyceridemia triggered acute pancreatitis in pregnancy - diagnostic approach, management and follow-up care.

Authors:  Gheorghe Cruciat; Georgiana Nemeti; Iulian Goidescu; Stefan Anitan; Andreea Florian
Journal:  Lipids Health Dis       Date:  2020-01-04       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.